Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Double probe heat therapy could slash cervical cancer risk in HIV-Positive women

NCT ID NCT07468695

First seen Mar 15, 2026 · Last updated Jun 23, 2026 · Updated 12 times

Summary

This study tests whether using two heat probes instead of one can better prevent cervical cancer in women living with HIV, who face a much higher risk. Researchers will enroll 300 women in Kenya to see if the two-probe method is safe, acceptable, and more effective at clearing HPV. If it works, this simple procedure could be a game-changer for cervical cancer prevention in low-resource settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Coptic Hope Center

    Nairobi, Kenya

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

thermal ablation (heat treatment) with one or two probes

What this could lead to

If successful, this could provide a more effective way to prevent cervical cancer in women with HIV, reducing cancer rates in high-risk populations.

What could go wrong

This is an early feasibility study with only 300 participants, so results may not apply broadly. The two-probe technique might not improve outcomes and could have unknown risks.

Conditions

The condition(s) this trial relates to.

AIDS cervical intraepithelial neoplasia dysplasia of cervix HIV infectious disease human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.